Table 3.
Overall survival | ||||
---|---|---|---|---|
Univariate | Multivariate | |||
Variables | RR (95% CI) | P value | RR (95% CI) | P value |
Primary location | 0.603 (0.407–0.893) | 0.012 | 0.569 (0.377–0.858) | 0.007 |
T stage | 1.384 (0.190–10.062) | 0.748 | ||
LVI | 1.182 (0.819–1.708) | 0.372 | ||
PNI | 1.456 (0.722–2.937) | 0.293 | ||
N stage | 1.123 (0.267–4.717) | 1.123 | ||
Regional LNs | 0.981 (0.948–1.016) | 0.281 | ||
Metastasis LNs | 1.055 (1.006–1.106) | 0.207 | ||
Sex | 1.260 (0.873–1.817) | 0.217 | ||
Diameter of LM | 1.766 (1.233–2.530) | 0.002 | 2.622 (1.618–4.248) | 0.001 |
Neo-chemo | 1.122 (0.654–1.925) | 0.676 | ||
Histological type | 1.733 (1.273–2.357) | 0.001 | 0.194 (0.075–0.501) | 0.001 |
CA199 | 1.727 (1.209–2.466) | 0.003 | ||
Number of LM | 2.330 (1.279–4.246) | 0.006 | 2.134 (1.420–3.205) | 0.001 |
CEA | 1.926 (1.309–2.834) | 0.001 | 1.624 (1.054–2.503) | 0.028 |
Systemic chemo | 0.738 (0.458–1.190) | 0.213 | 0.582 (0.350–0.968) | 0.037 |
Palliative resection | 1.542 (1.065–2.232) | 0.022 | 1.034 (0.973–1.098) | 0.285 |
RR risk ratio, CI confidence interval, LVI lymphovascular invasion, PNI perineural invasion, LNs lymph nodes, LM liver metastasis, Neo-chemo neoadjuvant chemotherapy, Chemo chemotherapy, CEA carcinoembryonic antigen, CA cancer antigen